HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weijia Fang Selected Research

Weijia Fang Research Topics

Disease

19Neoplasms (Cancer)
12/2022 - 07/2011
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2016
10Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 06/2014
6Neoplasm Metastasis (Metastasis)
01/2021 - 10/2012
5Stomach Neoplasms (Stomach Cancer)
07/2015 - 01/2012
3Hand-Foot Syndrome
01/2021 - 12/2012
3Disease Progression
11/2020 - 03/2019
3Diarrhea
01/2020 - 12/2012
3Lymphatic Metastasis
05/2017 - 05/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014 - 08/2011
3Adenocarcinoma of Lung
07/2014 - 07/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 05/2015
2Hepatitis B
01/2021 - 01/2020
2Exanthema (Rash)
01/2020 - 12/2012
2Carcinoma (Carcinomatosis)
02/2016 - 05/2013
1Cholangiocarcinoma
01/2022
1Inflammation (Inflammations)
01/2022
1Hypertension (High Blood Pressure)
01/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Colonic Neoplasms (Colon Cancer)
10/2020
1Microsatellite Instability
10/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2020
1Infections
01/2020
1Nausea
01/2020
1Neutropenia
01/2020
1Vomiting
01/2020
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2018
1Carcinogenesis
10/2012
1End Stage Liver Disease
06/2011

Drug/Important Bio-Agent (IBA)

5Cetuximab (Erbitux)FDA Link
12/2021 - 01/2017
4Programmed Cell Death 1 ReceptorIBA
01/2022 - 08/2015
4camrelizumabIBA
09/2021 - 01/2020
4GemcitabineFDA Link
01/2021 - 05/2013
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 09/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 10/2012
3Immune Checkpoint InhibitorsIBA
10/2020 - 01/2020
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 07/2014
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2013
3icotinibIBA
07/2014 - 07/2012
2LigandsIBA
12/2022 - 01/2020
2AlbuminsIBA
01/2021 - 11/2020
2Sorafenib (BAY 43-9006)FDA Link
01/2021 - 11/2020
2Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2018
2Capecitabine (Xeloda)FDA Link
01/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2014
2Biological ProductsIBA
01/2020 - 01/2014
2Circulating Tumor DNAIBA
03/2019 - 01/2019
2Indicators and Reagents (Reagents)IBA
05/2017 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 06/2014
2Proteins (Proteins, Gene)FDA Link
02/2016 - 10/2012
2PlatinumIBA
09/2014 - 05/2013
1NK Cell Lectin-Like Receptor Subfamily KIBA
12/2022
1Small Cytoplasmic RNAIBA
01/2022
1Apolipoproteins E (ApoE)IBA
01/2022
1Interleukin-33IBA
12/2021
1SmokeIBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1apatinibIBA
01/2021
1Serum AlbuminIBA
11/2020
1pembrolizumabIBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Cytotoxins (Cytolysins)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Fluorouracil (Carac)FDA LinkGeneric
01/2020
1NivolumabIBA
01/2020
1pazopanibFDA Link
01/2020
1B7-H1 AntigenIBA
01/2020
1brigatinibIBA
01/2019
1CrizotinibIBA
01/2019
1Cathepsin BIBA
02/2016
1CytokinesIBA
08/2015
1Tumor Biomarkers (Tumor Markers)IBA
08/2015
1Neoplasm Antigens (Tumor Antigens)IBA
08/2015
1Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA
05/2015
1Transaminases (Aminotransferases)IBA
07/2014
1Pemetrexed (MTA)FDA Link
07/2014
1ParaffinIBA
06/2014
1Formaldehyde (Formol)FDA Link
06/2014
1Vascular Endothelial Growth Factor CIBA
10/2012
1Vascular Endothelial Growth Factor DIBA
10/2012
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2012
1EnzymesIBA
01/2012
1celastrolIBA
08/2011
1Interleukin-18 (Interleukin 18)IBA
06/2011

Therapy/Procedure

13Therapeutics
01/2021 - 07/2014
9Immunotherapy
01/2022 - 01/2019
9Drug Therapy (Chemotherapy)
01/2022 - 07/2011
3Precision Medicine
01/2021 - 01/2019
2Aftercare (After-Treatment)
11/2020 - 05/2020
1Neoadjuvant Therapy
01/2021
1Adjuvant Chemotherapy
02/2017
1Gastrectomy
01/2014
1Laparotomy
07/2011